v3.25.4
SCHEDULE OF CONSOLIDATED FINANCIAL STATEMENTS (Details)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Global BioMedical Inc. [Member]    
State or other jurisdiction of incorporation or organization Nevada  
Date of incorporation or formation Apr. 18, 2017  
Attributable interest percentage 90.90% 90.90%
Global BioLife Inc. [Member]    
State or other jurisdiction of incorporation or organization Nevada  
Date of incorporation or formation Apr. 14, 2017  
Attributable interest percentage 81.80% 81.80%
BioLife Sugar Inc [Member]    
State or other jurisdiction of incorporation or organization Nevada  
Date of incorporation or formation Apr. 23, 2018  
Attributable interest percentage 90.90% 90.90%
Happy Sugar Inc [Member]    
State or other jurisdiction of incorporation or organization Nevada  
Date of incorporation or formation Aug. 17, 2018  
Attributable interest percentage 81.80% 81.80%
Sweet Sense Inc. [Member]    
State or other jurisdiction of incorporation or organization Nevada  
Date of incorporation or formation Apr. 30, 2018  
Attributable interest percentage 95.50% 95.50%
Global Sugar Solutions Inc. [Member]    
State or other jurisdiction of incorporation or organization Nevada  
Date of incorporation or formation Nov. 07, 2019  
Attributable interest percentage 100.00% 100.00%
Impact Biolife Science Inc [Member]    
State or other jurisdiction of incorporation or organization Nevada  
Date of incorporation or formation Apr. 13, 2021  
Attributable interest percentage 100.00% 100.00%
DSS Biomedical International Inc [Member]    
State or other jurisdiction of incorporation or organization Nevada  
Date of incorporation or formation Apr. 09, 2021  
Attributable interest percentage 100.00% 100.00%
DSS Biolife International Inc [Member]    
State or other jurisdiction of incorporation or organization Nevada  
Date of incorporation or formation Apr. 09, 2021  
Attributable interest percentage 100.00% 100.00%